Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
Elutra®
Cell Separation System*
Overview Specifications Materials
March 2021 we announced the sunset of the Elutra system effective May 2025 for system and services and December 2025 for consumables. Please contact your sales representative for further information.
Specifications

TUBING SET

Separation chamber volume: 40 mL
Number of collection bags: 6
Plastic: non-pyrogenic, biocompatible, sterilized with ethylene oxide

USER CONFIGURABLE PROFILES

Nine, including a sample monocyte enrichment protocol

MANUAL MODE

Pumps, centrifuge speed and ramp rates are fully controlled by the operator

EQUIPMENT

Centrifuge speed: 300 rpm to 2,600 rpm
Pump flow rates: 0 mL/min to 150 mL/min
Elutriation media volume: 500 mL to 12,000 mL
Fraction collection capability: 12

EQUIPMENT

Weight: 177 kg (389 lb)
Height: 180.3 cm (71 in)
Width: 70 cm (27.6 in)
Depth: 68 cm (26.7 in)

LINE VOLTAGE

100 ± 10% V AC, 50/60 Hz
115 ± 10% V AC, 50/60 Hz
230 ± 10% V AC, 50/60 Hz
240 ± 10% V AC, 50/60 Hz

INPUT LINE CURRENT

8 A maximum RMS at 100/115 V AC
4 A maximum RMS at 230/240 V AC

1Read EJ, Carter CS, Khuu HM, Taylor L, Taga TM. Evaluation of a closed automated system to isolate PBMC for DC immunotherapy. Cytotherapy. 2003;5(5,Suppl):456.

2 Powell DJ, Brennan AL, Zheng Z, Huynh H, Cotte J, Levine BL. Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program. Cytotherapy. 2009.11(7):923-935.

Typical results based on cell counts from a leukapheresis product collected the previous day from normal donors on a COBE® Spectra Apheresis System. 80 mL to 230 mL products contained 5 to 14 × 109 WBC count, 80 percent to 100 percent mononuclear cell and 1.8 mL to 4.7 mL red blood cell volume.

*Customers are responsible for validating the use of the Elutra system to separate cells for their intended therapy.

​​​​​​​​​​​​​

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}